Mutagen sensitivity, tobacco smoking and breast cancer risk: A case-control study

Carcinogenesis

Volumn 31, Issue 4, 2010, Pages 654-659

  Kosti, Ourania ^a   Byrne, Celia ^a   Meeker, Katherine L ^a   Watkins, Kenshata M ^a   Loffredo, Christopher A ^a   Shields, Peter G ^a   Schwartz, Marc D ^b   Willey, Shawna C ^c   Cocilovo, Costanza ^c   Zheng, Yun Ling ^a  

^a Carcinogenesis Biomarkers and Epidemiology Program ^*  (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; MUTAGENIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTAGEN TESTING; NEGRO; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; AGED; BREAST TUMOR; DNA REPAIR; ESTROGEN THERAPY; MENOPAUSE; MIDDLE AGED; RISK; STATISTICAL MODEL;

ADULT; AGED; BLEOMYCIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA REPAIR; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; MUTAGENS; ODDS RATIO; RISK; SMOKING;

EID: 77950888588     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq017     Document Type: Article

References (56)

1. Parkin, D.M. et al. (2006) Use of statistics to assess the global burden of breast cancer. Breast J., 1, S70-S80.
2. Stewart, S.L. et al. (2004) Cancer mortality surveillance-United States, 1990-2000. MMWR, 53, 1-108.
3. Smigal, C. et al. (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J. Clin., 56, 168-183.
4. Madigan, M.P. et al. (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl Cancer Inst., 87, 1681-1685.
5. Peto, J. et al. (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl Cancer Inst., 91, 943-949.
6. Turnbull, C. et al. (2008) Genetic predisposition to breast cancer: past, present, and future. Annu. Rev. Genomics Hum. Genet., 9, 321-345.
7. Pharoah, P.D. et al. (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med., 358, 2796-2803.
8. Garcia-Closas, M. et al. (2008) Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin. Cancer Res., 14, 8000-8009.
9. Weber, B.L. et al. (2000) Low penetrance genes associated with increased risk for breast cancer. Eur. J. Cancer, 36, 1193-1199.
10. Wu, X. et al. (2007) Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res., 67, 3493-3495.
11. Hsu, T.C. et al. (1991) Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 1, 83-89.
12. Schantz, S.P. et al. (1990) Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J. Natl Cancer Inst., 82, 1773-1775.
13. Cloos, J. et al. (1996) Genetic susceptibility to head and neck squamous cell carcinoma. J. Natl Cancer Inst., 88, 530-535.
14. Spitz, M.R. et al. (1994) Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J. Natl Cancer Inst., 86, 1681-1684.
15. Zheng, Y.L. et al. (2003) Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis, 24, 269-274.
16. Spitz, M.R. et al. (1995) Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol. Biomarkers Prev., 4, 99-103.
17. Wei, Q. et al. (1996) Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res., 56, 3975-3979.
18. Wu, X. et al. (1998) Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev., 7, 567-570.
19. Xiong, P. et al. (2001) Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res., 61, 8465-8469.
20. Jyothish, B. et al. (1998) DNA repair proficiency: a potential marker for identification of high risk members in breast cancer families. Cancer Lett., 124, 9-13.
21. Natarajan, T.G. et al. (2006) gamma-radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay. Cancer Epidemiol. Biomarkers Prev., 15, 437-442.
22. Zheng, Y.L. et al. (2009) Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis, 30, 1380-1386.
23. Berwick, M. et al. (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl Cancer Inst., 92, 874-897.
24. John, E.M. et al. (1993) Radiation and other environmental exposures and breast cancer. Epidemiol. Rev., 15, 157-162.
25. Xu, Y.J. et al. (1998) Excision of C-4'-oxidized deoxyribose lesions from double-stranded DNA by human apurinic/apyrimidinic endonuclease (Ape1 protein) and DNA polymerase beta. J. Biol. Chem., 273, 28837-28844.
26. Dar, M.E. et al. (1997) Identification of defective illegitimate recombinational repair of oxidatively-induced DNA double-strand breaks in ataxiatelangiectasia cells. Mutat. Res., 384, 169-179.
27. Shou, M. et al. (1993) Reactivity of benzo[a]pyrene-7, 8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis, 14, 475-482.
28. Rossouw, J.E. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
29. Bush, T.M. et al. (2007) How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes. J. Gen. Intern. Med., 22, 1311-1316.
30. Terry, P.D. et al. (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol. Biomarkers Prev., 11, 953-971.
31. Li, C.I. et al. (2005) The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control, 16, 975-985.
32. Al-Delaimy, W.K. et al. (2004) A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol. Biomarkers Prev., 13, 398-404.
33. Kropp, S. et al. (2002) Active and passive smoking and risk of breast cancer by age 50 years among German women. Am. J. Epidemiol., 156, 616-626.
34. Reynolds, P. et al. (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J. Natl. Cancer Inst., 96, 29-37.
35. Egan, K.M. et al. (2002) Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology, 13, 138-145.
36. O'Connell, D.L. et al. (1987) Cigarette smoking, alcohol consumption, and breast cancer risk. J. Natl Cancer Inst., 78, 229-234.
37. Ghadirian, P. et al. (2004) Smoking and the risk of breast cancer among carriers of BRCA mutations. Int. J. Cancer, 110, 413-416.
38. Ranocchia, D. et al. (1991) Cigarette smoke and the hormonal receptors status in breast cancer. Eur. J. Epidemiol., 7, 389-395.
39. Brunet, J.S. et al. (1998) Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J. Natl Cancer Inst., 90, 761-766.
40. Lin, Y. et al. (2008) Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J. Epidemiol., 18, 77-83.
41. Band, P.R. et al. (2002) Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet, 360, 1044-1049.
42. Kaufman, D.W. et al. (1980) Cigarette smoking and age at natural menopause. Am. J. Public Health, 70, 420-422.
43. Weisberg, E. (1985) Smoking and reproductive health. Clin. Reprod. Fertil., 3, 175-186.
44. Jensen, J. et al. (1988) Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol., 159, 820-825.
45. Key, T.J. et al. (1996) Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br. J. Cancer, 74, 1313-1316.
46. Gammon, M.D. et al. (1998) Cigarette smoking and breast cancer risk among young women (United States). Cancer Causes Control, 9, 583-590.
47. Couch, F.J. et al. (2001) Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol. Biomarkers Prev., 10, 327-332.
48. Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada). (2008) Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res. Treat., 109, 67-75.
49. Ambrosone, C.B. et al. (2008) Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol. Biomarkers Prev., 17, 15-26.
50. Mechanic, L.E. et al. (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis, 27, 1377-1385.
51. Metsola, K. et al. (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res., 7, R987-R997.
52. Pachkowski, B.F. et al. (2006) XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res., 66, 2860-2868.
53. Shen, J. et al. (2005) Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 336-342.
54. Shore, R.E. et al. (2008) Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int. J. Cancer, 122, 2101-2105.
55. Duell, E.J. et al. (2001) Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomarkers Prev., 10, 217-222.
56. Cloos, J. et al. (1999) Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J. Natl. Cancer Inst., 91, 1125-1130.